Aarti Industries Limited reported Q1 FY27 consolidated revenue from operations of ₹23.87 billion, up 27.85% year-over-year. The specialty chemical manufacturer delivered a consolidated net profit of ₹1.55 billion, supported by operational recovery, stable raw material pricing, and strong volume growth across its benzene derivative supply chains.
MUMBAI, July 30, 2026 — Specialty chemicals and pharmaceuticals manufacturer Aarti Industries Limited announced its financial results for the first quarter ending June 30, 2026 (Q1 FY27) on Thursday, July 30, 2026. The company posted consolidated revenue from operations of ₹23.87 billion (₹2,387 crore), reflecting a 27.85 percent year-over-year expansion. According to corporate disclosures submitted to domestic stock exchanges, Aarti Industries logged a consolidated net profit after tax (PAT) of ₹1.55 billion (₹155 crore) for the April–June quarter. The sharp uptick in earnings marks a operational recovery from inventory shocks and raw material volatility experienced in the previous fiscal year.
Operating Margin Expansion and Product Portfolio Drivers
The quarterly revenue of ₹23.87 billion was driven by expanded demand across the company's core specialty chemical verticals, including nitrotoluene, chlorobenzene, and downstream benzene-based derivatives. Consolidated net profit surged to ₹1.55 billion from ₹430 million (₹43 crore) recorded in Q1 FY26, when severe inventory destocking and falling chemical product realizations weighed on operating margins.
Operating profit margins during the June quarter benefited from raw material price stabilization, increased capacity utilization at recently commissioned production units, and improved export realizations across agrochemical and pharmaceutical intermediates. Total consolidated operating expenses for the quarter stood at ₹22.11 billion (₹2,211 crore).
| Financial Parameter | Q1 FY27 Consolidated Official Metric | Q1 FY26 Consolidated Official Metric | Year-over-Year Shift |
| Revenue from Operations | ₹23.87 Billion (₹2,387 Crore) | ₹18.67 Billion (₹1,867 Crore) | +27.85% |
| Consolidated Net Profit (PAT) | ₹1.55 Billion (₹155 Crore) | ₹0.43 Billion (₹43 Crore) | +260.47% |
| Standalone Operational Revenue | ₹22.41 Billion (₹2,241 Crore) | — | — |
| Standalone Net Profit (PAT) | ₹1.44 Billion (₹144 Crore) | — | — |
Capacity Utilization and Strategic Agrochemical Contracts
Aarti Industries continues to scale operations across its greenfield manufacturing units at Jhagadia and Dahej in Gujarat. Growth during the quarter was further supported by long-term supply agreements, including a $150 million multi-year contract signed with a global agrochemical major to supply specialty intermediates through 2030.
Industry analysts note that Indian specialty chemical producers are benefiting from global supply chain diversification and stabilized freight costs. Management's strategic investments in Zone IV expansion projects have added high-value chemical product lines, improving margin resilience against global commodity cycles.
Official Sources Section
According to official corporate filings submitted by Aarti Industries Limited under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the quarterly results were reviewed by the Audit Committee and approved by the Board of Directors on July 30, 2026. Financial results were formally logged with BSE Limited and the National Stock Exchange of India. Regulatory oversight remains under the Securities and Exchange Board of India (SEBI).
Quote Section
"According to officials and regulatory filings submitted to stock exchanges, the board approved the financial outcomes, reflecting improved demand volume absorption and margin recovery across key specialty chemical product chains."
Why It Matters
Aarti Industries' first-quarter financial recovery provides a key gauge for the health of India's specialty chemical sector. For institutional investors and industrial consumers, steady volume growth and margin stabilization signal that destocking cycles across global agrochemical and industrial chemical markets are giving way to sustained demand recovery.
Key Facts at a Glance
Consolidated Revenue: Aarti Industries posts Q1 FY27 revenue from operations of ₹23.87 billion, up 27.85% YoY.
Net Profit Surge: Quarterly post-tax net profit reaches ₹1.55 billion, expanding significantly from ₹430 million in Q1 FY26.
Standalone Results: Standalone operational revenue stood at ₹22.41 billion with net profit at ₹1.44 billion.
Exchange Reporting: Official audited financial statements submitted to BSE Limited and the National Stock Exchange of India.
Frequently Asked Questions (FAQs)
What was Aarti Industries' consolidated revenue for Q1 FY27?
Aarti Industries Limited reported consolidated revenue from operations of ₹23.87 billion (₹2,387 crore) for the quarter ending June 30, 2026.
How much net profit did Aarti Industries deliver in the June quarter?
The company posted a consolidated net profit after tax of ₹1.55 billion (₹155 crore) for Q1 FY27, up from ₹430 million in Q1 FY26.
What driven the profit growth in Q1 FY27 compared to Q1 FY26?
Growth was driven by higher volume throughput in benzene derivatives, pricing stability, and a recovery from inventory losses and raw material volatility experienced in the prior-year quarter.
Where can investors access official financial filings for Aarti Industries?
Official earnings reports and corporate announcements are accessible on the web portals of BSE Limited, the National Stock Exchange of India, and Aarti Industries Limited.
Source: BSE Limited, National Stock Exchange of India, Aarti Industries Limited, Securities and Exchange Board of India